Avior Wealth Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
8,529
+1,730
| +25% | +$56.2K | 0.01% | 589 |
|
|
2025
Q1 | $257K | Buy |
6,799
+343
| +5% | +$13K | 0.01% | 590 |
|
|
2024
Q4 | $528K | Buy |
6,456
+1,124
| +21% | +$92K | 0.02% | 434 |
|
|
2024
Q3 | $609K | Sell |
5,332
-499
| -9% | -$57K | 0.02% | 406 |
|
|
2024
Q2 | $440K | Buy |
5,831
+1,129
| +24% | +$85.3K | 0.02% | 466 |
|
|
2024
Q1 | $321K | Buy |
4,702
+32
| +0.7% | +$2.19K | 0.01% | 561 |
|
|
2023
Q4 | $293K | Buy |
4,670
+1,183
| +34% | +$74.3K | 0.02% | 455 |
|
|
2023
Q3 | $178K | Buy |
+3,487
| New | +$178K | 0.01% | 545 |
|